This inventor holds 6 USPTO granted patents. Top assignee: The Upjohn Co.. Active years: 1978-1988.
Location History:
- Portage, MI (US) (1980 - 1981)
- Kalamazoo, MI (US) (1978 - 1988)
Company Filing History:
Years Active: 1978-1988
Title: David W Elrod: Innovator in Antibiotic Development
Introduction
David W Elrod is a notable inventor based in Kalamazoo, MI (US), recognized for his contributions to the field of antibiotics. With a total of 6 patents, Elrod has made significant advancements in the development of novel antimicrobial agents.
Latest Patents
Among his latest patents is the invention of Nobamycin and its analogs, which concerns a novel nogamycin with a previously unknown configuration. This invention includes methods for producing substituted and unsubstituted nogamycin in an essentially pure isomeric form. Another significant patent is for the process of producing 10.dbd.dihydrosteffimycin, which involves the carbon 10 ketonic carbonyl reduction in fermentation processes. This process utilizes known antibiotics steffimycin and steffimycin B as starting materials. The resulting antibiotics are effective against various microorganisms, including Bacillus subtilis, Bacillus cereus, Sarcina lutea, Streptococcus pyogenes, and Mycobacterium avium. These antibiotics can inhibit the growth of these microorganisms in various environments.
Career Highlights
David W Elrod is associated with The Upjohn Company, where he has contributed to the research and development of innovative antibiotic solutions. His work has been pivotal in addressing the challenges posed by microbial resistance.
Collaborations
Elrod has collaborated with notable colleagues, including Paul F Wiley and Vincent P Marshall, enhancing the research efforts in antibiotic development.
Conclusion
David W Elrod's innovative work in the field of antibiotics showcases his commitment to advancing medical science. His patents reflect a dedication to creating effective solutions against microbial threats.